HCPCS Code Q4162: Skin substitute billing guide

HCPCS Code Q4162 is the Level II Q-code for WoundEx Flow and BioSkin Flow. It covers a flowable skin substitute billed in 0.5 cc units, not per square centimeter. Two rules changed for this code on January 1, 2026.

Application is now reported with HCPCS G0681-G0684 rather than the CPT 15271-15278 series. The product itself is packaged into that application service instead of being paid separately.

This guide covers the official descriptor, the current Medicare payment rules, required diagnosis codes, the billing workflow, and the denial patterns that followed the change.

Found our content helpful?

Key takeaways

HCPCS Code Q4162 covers WoundEx Flow and BioSkin Flow, a non-sheet flowable skin substitute billed in 0.5 cc units

Since January 1, 2026, application of a flowable product is reported with G0681-G0684; CPT 15271-15278 now covers sheet products only

Q4162 is packaged into the application service, so the product line does not generate its own Medicare allowance

The flat national rate of about $127.14 per sq cm applies to sheet products under APCs 6000, 6001 and 6002, not to Q4162

JW and JZ modifiers are rejected on skin substitute claims for dates of service from January 1, 2026

The skin substitute LCDs due to start in 2026 were withdrawn in December 2025; Novitas, First Coast and CGS apply their existing policies

Pabau’s claims management tools support HCPCS Q-code entry and documentation capture for wound care billing

HCPCS Code Q4162: Official descriptor and product details

HCPCS Code Q4162 is the CMS-assigned Level II code for WoundEx Flow and BioSkin Flow, 0.5 cc. The Centers for Medicare and Medicaid Services (CMS) maintains the Q4100-Q4200 series as temporary codes for individual skin substitute products. Q4162 sits in the non-sheet branch of that series, which matters for both the unit count and the payment route.

A flowable product is supplied as a volume, not as a sheet cut to the wound. That is why the descriptor names a volume of 0.5 cc and why the unit count is not a square-centimeter figure.

Key facts for any Q4162 claim:

Because Q-codes are temporary designations, always verify the descriptor against the current CMS HCPCS quarterly release before submitting claims. Codes in this series can be reassigned, retired, or have their descriptors updated mid-year.

How Medicare pays for Q4162 in 2026

Medicare no longer pays Q4162 as a separately payable biological. Since January 1, 2026, CMS treats most non-BLA skin substitute products as incident-to supplies rather than as drugs priced from average sales price (ASP). Q4162 is a non-sheet product, and non-sheet products stay packaged into the application service for CY 2026.

The change came from two final rules: the CY 2026 Physician Fee Schedule rule (CMS-1832-F) and the CY 2026 OPPS and ASC rule (CMS-1834-FC).

For sheet products, CMS deliberately unpackaged the product cost into three new APCs, 6000, 6001 and 6002, each carrying status indicator S1. Those APCs pay a single flat national rate of roughly $127.14 per square centimeter for CY 2026.

That flat per-square-centimeter rate does not reach Q4162. It applies to sheet products, and a flowable product is not billed by surface area at all. Reading the 2026 model as one rate for every skin substitute is a common and expensive mistake. The comparison below sets the old rules against the current ones, line by line.

How payment actually reaches a Q4162 claim

Payment arrives through the application code, not through the product code. In the office setting, the non-sheet application codes G0681-G0684 carry their own relative value units and are paid under the Physician Fee Schedule.

The allowed amount reflects those RVUs, the documented wound surface area, the local geographic indices, and the annual conversion factor.

Q4162 is still reported on the claim, with units, on the same date of service as the application code. It does not generate a separate allowance of its own. In the hospital outpatient setting the packaging is tighter still, since CMS assigned the non-sheet application codes a packaged status indicator effective April 1, 2026.

Only products licensed under Section 351 of the Public Health Service Act remain on ASP-based separate payment. Q4162 is not one of them, so a prior-year ASP figure for this code no longer predicts what Medicare will pay.

Discarded product is no longer billable either. The JW and JZ modifiers are not permitted on skin substitute claims. Claims carrying either modifier are rejected for dates of service on or after January 1, 2026. Bill only the volume actually administered.

Checking the remittance advice after adjudication is the fastest way to confirm which line paid. On a correctly built 2026 claim, the payment sits on the G-code line and the Q4162 line adjudicates at zero.

Coverage after the 2026 LCD withdrawal

There is no current Local Coverage Determination governing skin substitute grafts and cellular or tissue-based products. The A/B MACs withdrew the LCDs that were scheduled to take effect on January 1, 2026, and CMS announced the withdrawal on December 24, 2025.

Coverage now rests on the policies that were already in force. Three contractors kept theirs: Novitas Solutions, CGS Administrators, and First Coast Service Options. Their retirement dates were removed, so practices in those jurisdictions follow the same criteria they used before.

The remaining jurisdictions have no published skin substitute LCD. There, each claim is judged case by case against the reasonable-and-necessary standard, which puts more weight on the medical necessity narrative in the chart.

How to bill Q4162 for wound care: Step-by-step workflow

Billing HCPCS Code Q4162 correctly means pairing it with a non-sheet application code and converting the volume applied into 0.5 cc units. The discarded-portion modifiers stay off the claim. Missing any one of these steps is enough to trigger a denial.

1. Measure the wound before application. Document length and width in centimeters in the progress note, then multiply for total wound surface area. That surface area selects the application code. It does not set the Q4162 unit count.
2. Select the application code from the G0681-G0684 series. G0681 covers the first 25 sq cm of a wound smaller than 100 sq cm, and G0682 covers each additional 25 sq cm. G0683 covers the first 100 sq cm of a wound of 100 sq cm or more, and G0684 covers each additional 100 sq cm.
3. Do not use CPT 15271-15278. That series now applies only to the application of sheet products. Pairing it with a flowable product is the most common way a 2026 claim ends up built on the 2025 model.
4. Convert the volume to units. One Q4162 unit equals 0.5 cc, so 2 cc of product applied is 4 units. Counting units in square centimeters instead is the leading unit-entry error on this code.
5. Leave JW and JZ off the claim. Bill only the volume administered. Discarded product is not payable, and either modifier triggers a rejection.
6. Report both lines together. The product code and the application code must appear on the same claim and the same date of service, even though Q4162 itself is packaged.
7. Confirm place of service. The application code pays differently in the office (POS 11) and in a facility (POS 22). The wrong POS code pays the claim at the wrong rate.
8. Attach a supported ICD-10 code and submit with complete documentation. The progress note should show wound dimensions, the volume applied, the product label information, and the medical necessity rationale.

Accurate billing starts at the point of service. Capturing wound measurements and the volume applied electronically at the visit reduces transcription errors before the claim ever reaches the payer.

Required ICD-10 diagnosis codes for Q4162

The diagnosis codes accepted alongside Q4162 now depend on which MAC processes the claim. Novitas, CGS and First Coast each publish a covered diagnosis list in the skin substitute policy they retained.

In every other jurisdiction there is no published list, so the diagnosis has to carry medical necessity on its own. The table below shows the categories that appear most often on paid wound care claims.

Check your contractor’s coverage page each time it is revised. A retained policy can still be updated, and a diagnosis that was accepted under an earlier version may have been dropped. Each ulcer code carries its own laterality and staging requirements, which the ICD-10-CM code library sets out in full.

Payer policies and coverage limits beyond Medicare

Medicare sets the floor for Q4162 coverage, but commercial payers often apply stricter criteria. Many have not adopted the 2026 packaging model at all. Checking eligibility before each visit reveals whether the plan covers skin substitutes, and whether prior authorization is required.

Common payer policy variations to track:

• Application code expectations: Some commercial payers still expect CPT 15271-15278 on a flowable product claim. Confirm which application series the plan wants before you submit.
• Prior authorization: Required by many commercial payers for skin substitute applications, and not a blanket Medicare requirement.
• Application frequency limits: Payers typically cap the number of applications per wound episode, often at one application per wound in a four-week period.
• Covered wound types: Some plans restrict coverage to diabetic foot ulcers or venous leg ulcers only, excluding post-surgical wounds.
• Step therapy requirements: Several payers want documentation that standard care failed first, including debridement, compression, or offloading.
• Product-specific approval: Each Q-code maps to a named product, so a formulary may approve some and not others. Confirm Q4162 is listed before ordering.

Keeping payer-specific policy documentation current beats applying one set of Medicare rules to every submission. Reconfirm the policy at each renewal cycle, since skin substitute criteria were widely rewritten during 2026.

Documentation requirements for Q4162 claims

Documentation problems sit close behind unit and application-code errors as a cause of Q4162 denials. The progress note has to stand alone as evidence of medical necessity. An auditor reading only the chart note should see why a flowable skin substitute was the right choice.

A complete Q4162 claim package includes:

• Wound measurement: Length and width in centimeters at each application visit. The resulting surface area must support the G-code selected.
• Volume applied: The number of cc administered, recorded in the note. This is what the Q4162 unit count is converted from, so the two must agree.
• Prior treatment history: Documentation that conservative wound care was tried before escalating to a skin substitute.
• Product label and lot number: Retain the label from the package applied. Many auditors require it as proof the product was administered.
• Medical necessity narrative: A brief note covering wound duration, wound classification, and the failure to respond to standard care. This matters most in jurisdictions with no published LCD.
• Progress photographs: Not always mandatory, but wound photographs at each visit give strong support during an audit or appeal.
• Signed order or prescription: Some contractors expect a physician order for skin substitute application; confirm the requirement for your jurisdiction.

Build an encounter form that captures wound dimensions and applied volume alongside the Q-code line. It cuts the documentation burden at billing time and keeps unit counts tied to the clinical record.

Q4162 compared to related skin substitute HCPCS codes

The Q4100-Q4200 series assigns a unique code to each skin substitute product. Q4162 is not interchangeable with the others, even where the products look clinically similar. The sheet and non-sheet split matters most, because it decides both the unit of measure and the application code series.

Confirm the current descriptor for Q4162 with the AAPC HCPCS code lookup, then cross-reference it against the product you actually applied.

Common billing errors and denial reasons

Most Q4162 denials are preventable, and since January 2026 most of them share one root cause. The claim was built on the payment model that applied before the rules changed. Robust denial management strategies cut the time spent on rework and speed up payment.

A clean claim means every field is correct before it leaves your system. For Q4162 that covers the application code, the 0.5 cc unit count, and the ICD-10 pairing. It also covers the place of service, the supporting documentation, and the absence of a JW or JZ modifier.

How Pabau supports skin substitute and Q-code billing

Wound care practices billing HCPCS Code Q4162 run a multi-step documentation and billing workflow that breaks easily at any point. Practice management software like Pabau keeps that workflow in one system.

Its claims management software supports HCPCS Q-code entry alongside the companion application code, so both lines land in a single encounter record.

Wound dimensions and the volume applied get recorded digitally at the point of service, which keeps the figures tied to the claim. That is what stops the unit-count and application-code errors behind most Q4162 denials. Digital forms capture product lot numbers and application dates inside the clinical note, so the audit trail builds itself.

The result is a shorter path from application to payment. Your coder opens the encounter, finds the wound area and the volume applied already recorded, and builds both claim lines from the same note. Nobody has to chase the treating clinician for a measurement two weeks after the visit.

Streamline wound care billing with Pabau

Pabau’s claims management tools let wound care practices capture HCPCS Q-code entries, document wound measurements, and submit clean claims without switching between systems.

Book a demo

Conclusion

HCPCS Code Q4162 changed direction on January 1, 2026. The product code is still reported, but payment now runs through the G0681-G0684 application line rather than the product line. Most denials this year trace back to a claim built on the older model. That usually means a CPT application code, units counted by surface area, or a JW modifier on discarded product.

So the work to do now is unglamorous. Rebuild your Q4162 claim template around the G-code, retrain whoever enters units, and forecast revenue from the application allowable rather than the product. Practices that do this once stop rewriting the same denial every month.

Pabau’s claims management tools help wound care practices enter HCPCS Q-codes accurately and capture wound measurements and applied volume at the point of care. That record becomes the audit-ready documentation behind a clean claim. Book a demo to see how the Q4162 workflow would run in your practice.

Continue your research

Need a compliance overview for billing workflows? Medical billing compliance outlines the documentation and audit standards that apply to HCPCS and CPT claims.

Looking for a full HCPCS code reference? Medical billing fundamentals explains how HCPCS Level I and Level II codes fit within the overall billing framework.

Frequently asked questions